Copyright © 2006, European Society of Cardiology
Essential role of Rho/ROCK-dependent processes and actin dynamics in mediating leptin-induced hypertrophy in rat neonatal ventricular myocytes
Department of Physiology and Pharmacology, University of Western Ontario, London, ON, Canada
* Corresponding author. Tel.: +1 519 661 3872; fax: +1 519 661 3827. Email address: morris.karmazyn{at}schulich.uwo.ca
Background: Obesity is associated with increased leptin production, which may contribute to cardiac hypertrophy. Although leptin has been shown to produce cardiomyocyte hypertrophy, its mechanism of action is far from clear. Rho proteins have been suggested as major contributors to cardiac hypertrophy, although their potential role in mediating the effect of leptin has not been studied.
Methods: We determined the role of Rho and Rho-associated kinase (ROCK) as mediators of leptin-induced cell hypertrophy in cultured neonatal rat ventricular myocytes.
Results: Leptin (3.1 nmol/L) significantly increased cell surface area by 32±5% and leucine incorporation by 43±7%. These effects were associated with significant activation of RhoA to 450±40% of pre-leptin levels that was attenuated by pretreatment with an anti-leptin receptor (anti-OBR) antibody (166 ng/mL) to 120±20% of control values. Both the RhoA inhibitor C3 exoenzyme and ROCK inhibitor Y-27632 potently attenuated leptin-induced increased cell surface area and leucine incorporation. The hypertrophic effect of leptin was associated with an increase in phosphorylation of the actin binding protein cofilin to 290±20% of control values. In addition, the increase in polymerization of actin, as reflected by a decrease in the G/F-actin ratio, was significantly inhibited by both the anti-OBR antibody and Y-27632. Leptin-induced hypertrophy was also attenuated by disruption of actin filaments with 50 nmol/L latrunculin B. RhoA pathway inhibitors and latrunculin B also both attenuated leptin-induced ERK1/2 and p38 activation.
Conclusion: Our results indicate that the activation of Rho and actin dynamics play a pivotal role in leptin signaling leading to the development of cardiomyocyte hypertrophy.
KEYWORDS Neonatal cardiomyocytes; Hypertrophy; Leptin; Rho/ROCK; G-actin
Time for primary review 21 days
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Karmazyn, D. M. Purdham, V. Rajapurohitam, and A. Zeidan Signalling mechanisms underlying the metabolic and other effects of adipokines on the heart Cardiovasc Res, July 15, 2008; 79(2): 279 - 286. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Purdham, V. Rajapurohitam, A. Zeidan, C. Huang, G. J. Gross, and M. Karmazyn A neutralizing leptin receptor antibody mitigates hypertrophy and hemodynamic dysfunction in the postinfarcted rat heart Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H441 - H446. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Pemberton Leptin-induced cardiac hypertrophy: RhoAing a lipid raft down a protective p38 MAPK signalling stream? Cardiovasc Res, January 1, 2008; 77(1): 4 - 5. [Full Text] [PDF]
|
|
|
|
|
|
A. Zeidan, S. Javadov, S. Chakrabarti, and M. Karmazyn Leptin-induced cardiomyocyte hypertrophy involves selective caveolae and RhoA/ROCK-dependent p38 MAPK translocation to nuclei Cardiovasc Res, January 1, 2008; 77(1): 64 - 72. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. R. McGaffin, C.-K. Sun, J. J. Rager, L. C. Romano, B. Zou, M. A. Mathier, R. M. O'Doherty, C. F. McTiernan, and C. P. O'Donnell Leptin signalling reduces the severity of cardiac dysfunction and remodelling after chronic ischaemic injury Cardiovasc Res, January 1, 2008; 77(1): 54 - 63. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Zeidan, B. Paylor, K. J. Steinhoff, S. Javadov, V. Rajapurohitam, S. Chakrabarti, and M. Karmazyn Actin Cytoskeleton Dynamics Promotes Leptin-Induced Vascular Smooth Muscle Hypertrophy via RhoA/ROCK- and Phosphatidylinositol 3-Kinase/Protein Kinase B-Dependent Pathways J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1110 - 1116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Sharma, I. C. Okere, M. K. Duda, D. J. Chess, K. M. O'Shea, and W. C. Stanley Potential impact of carbohydrate and fat intake on pathological left ventricular hypertrophy Cardiovasc Res, January 15, 2007; 73(2): 257 - 268. [Abstract] [Full Text] [PDF]
|
|